Psoriasis

Current Studies

Active | Recruiting

Arcutis
ARQ-151-301

PHASE: 3

STATUS: Recruiting

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of roflumilast (topical) versus placebo for psoriasis in adolescent and adult patients.

COMPLETE DETAILS

Arcutis
ARQ-151-306

PHASE: 3

STATUS: Recruiting

SUMMARY:

Study (interventional: open-label extension) investigating the efficacy and safety of roflumilast (topical) for psoriasis in adolescent and adults.

COMPLETE DETAILS

Arcutis
ARQ-154-204

PHASE: 2

STATUS: Recruiting

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of roflumilast (topical) versus placebo for psoriasis in adolescent and adult patients.

COMPLETE DETAILS

Bausch Health
BHS-CAN-DERM-002

PHASE: 4

STATUS: Recruiting

SUMMARY:

Study (observational) investigating the efficacy and safety of brodalumab (injection) for psoriasis in adults.

COMPLETE DETAILS

Janssen
CNTO1959PSO3011

PHASE: 3

STATUS: Recruiting

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of guselkumab (injection) for psoriasis in children and adolescents.

COMPLETE DETAILS

Janssen
C0168Z03 (PSOLAR)

PHASE: 4

STATUS: Recruiting

SUMMARY:

Study (observational) investigating the efficacy and safety of systemic therapies (biologics) for psoriasis in adults.

COMPLETE DETAILS

Novartis
CAIN457ACA02 (PURE)

PHASE: 4

STATUS: Recruiting

SUMMARY:

Study (observational) investigating the efficacy and safety of secukinumab (injection) for psoriasis in adults.

COMPLETE DETAILS

Active | Not Yet Recruiting

No “Active | Not Yet Recruiting” Studies

Active | Not Recruiting

AbbVie
M15-997

PHASE: 3

STATUS: Not Recruiting

SUMMARY:

Study (interventional: open-label extension) investigating the efficacy and safety of risankizumab (injection) for psoriasis in adults.

COMPLETE DETAILS

Prior Studies

AbbVie
M16-008

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of risankizumab (injection) versus ustekinumab (injection) and placebo for psoriasis in adults.

AbbVie
M16-010

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of risankizumab (injection) versus adalimumab (injection) and placebo for psoriasis in adults.

AbbVie
M16-766

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of risankizumab (injection) versus secukinumab (injection) for psoriasis in adults.

Amgen
20120263

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of adalimumab biosimilar [ABP 501] versus adalimumab for psoriasis in adults.

Amgen
CC-10004-PSOR-001

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of apremilast (oral) versus placebo for psoriasis in adults.

Bausch Health
20120103

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of brodalumab (injection) versus ustekinumab (injection) and placebo for psoriasis in adults.

Coherus
CHS-0214-05

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: open-label extension) investigating the efficacy and safety of CHS-0214-05 (injection) for psoriasis in adults.

Coherus
CHS-0214-04

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of CHS-0214 versus etanercept for psoriasis in adults.

Eli Lilly
I1F-MC-RHBC

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of LY2439821 [ixekizumab] (injection) versus etanercept (injection) and placebo for psoriasis in adults with a long-term extension period.

Eli Lilly
I1F-MC-RHBS

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of ixekizumab (injection) versus ustekinumab (injection) versus placebo for psoriasis in adults.

Eli Lilly
I1F-MC-RHCD

PHASE: 3

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of ixekizumab (injection) versus placebo for psoriasis in children and adolescents.

LEO
LP0053-1030

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of betamethasone dipropionate-calcipotriol [LEO 90100] (topical) versus betamethasone dipropionate-calcipotriol (topical) for psoriasis in adults.

Takeda
M1-1188_203

PHASE:

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled and open-label extension) investigating the efficacy and safety of namilumab (injection) versus placebo for psoriasis in adults.

UCB
PS0007

PHASE: 3

STATUS: Completed

SUMMARY:

Study (interventional: randomized controlled) investigating the efficacy and safety of certolizumab (injection) for psoriasis in children and adolescents.